R-roscovitine ( DrugBank: R-roscovitine )


1 disease
IDDisease name (Link within this page)Number of trials
75Cushing disease2

75. Cushing disease


Clinical trials : 203 Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03774446
(ClinicalTrials.gov)
November 2, 20186/11/2018Multicenter Study of Seliciclib (R-roscovitine) for Cushing DiseaseA Phase 2 Multicenter Study of Seliciclib (R-roscovitine) for Cushing DiseaseCushing DiseaseDrug: SeliciclibCedars-Sinai Medical CenterNULLRecruiting18 YearsN/AAll29Phase 2United States
2NCT02160730
(ClinicalTrials.gov)
May 201421/5/2014Treatment of Cushing's Disease With R-roscovitineTreatment of Pituitary Cushing Disease With a Selective CDK Inhibitor, R-roscovitineCushings DiseaseDrug: R-roscovitineShlomo Melmed, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Terminated18 YearsN/AAll4Phase 2United States